{"id":"https://openalex.org/W4386562965","doi":"https://doi.org/10.1158/2767-9764.c.6826141.v1","title":"Data from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy","display_name":"Data from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy","publication_year":2023,"publication_date":"2023-09-08","ids":{"openalex":"https://openalex.org/W4386562965","doi":"https://doi.org/10.1158/2767-9764.c.6826141.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.c.6826141.v1","doi":"https://doi.org/10.1158/2767-9764.c.6826141.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.6826141.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.c.6826141.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006798929","display_name":"Kyle M. Garland","orcid":"https://orcid.org/0000-0003-0722-4245","observed_orcids":["https://orcid.org/0000-0003-0722-4245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyle M. Garland","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0722-4245","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032619799","display_name":"Alexander J. Kwiatkowski","orcid":"https://orcid.org/0000-0001-5435-3555","observed_orcids":["https://orcid.org/0000-0001-5435-3555"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander J. Kwiatkowski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5435-3555","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007263617","display_name":"John T. Tossberg","orcid":"https://orcid.org/0009-0005-2241-6730","observed_orcids":["https://orcid.org/0009-0005-2241-6730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John T. Tossberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-2241-6730","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056838759","display_name":"Philip S. Crooke","orcid":"https://orcid.org/0000-0003-3872-3290","observed_orcids":["https://orcid.org/0000-0003-3872-3290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip S. Crooke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3872-3290","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026728364","display_name":"Thomas M. Aune","orcid":"https://orcid.org/0000-0002-4968-4306","observed_orcids":["https://orcid.org/0000-0002-4968-4306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas M. Aune","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4968-4306","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037982412","display_name":"John T. Wilson","orcid":"https://orcid.org/0000-0002-9144-2634","observed_orcids":["https://orcid.org/0000-0002-9144-2634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John T. Wilson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9144-2634","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12610","display_name":"RNA regulation and disease","score":0.3774000108242035,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12610","display_name":"RNA regulation and disease","score":0.3774000108242035,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.28929999470710754,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.27250000834465027,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alu-rna","display_name":"Alu RNA","score":0.9700000286102295},{"id":"https://openalex.org/keywords/a-to-i-rna-editing","display_name":"A-to-I RNA editing","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/nanoparticle-delivery","display_name":"nanoparticle delivery","score":0.7350000143051147},{"id":"https://openalex.org/keywords/polymeric-nanoparticles","display_name":"polymeric nanoparticles","score":0.8510000109672546},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6869999766349792},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.382999986410141}],"concepts":[{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.8300507664680481},{"id":"https://openalex.org/C48931128","wikidata":"https://www.wikidata.org/wiki/Q412199","display_name":"Alu element","level":5,"score":0.7242785692214966},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5005736351013184},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.47946107387542725},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4608983099460602},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4519972801208496},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4139323830604553},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4132888913154602},{"id":"https://openalex.org/C21786251","wikidata":"https://www.wikidata.org/wiki/Q14886350","display_name":"RNA editing","level":4,"score":0.4100898504257202},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.40046700835227966},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3632206320762634},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34750664234161377},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23434433341026306},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15278670191764832},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1392633616924286},{"id":"https://openalex.org/C197077220","wikidata":"https://www.wikidata.org/wiki/Q720988","display_name":"Human genome","level":4,"score":0.13270825147628784},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.1063719093799591},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10409995913505554}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.c.6826141.v1","doi":"https://doi.org/10.1158/2767-9764.c.6826141.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.6826141.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.c.6826141.v1","doi":"https://doi.org/10.1158/2767-9764.c.6826141.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.6826141.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385954546","https://openalex.org/W4386541145","https://openalex.org/W4386559416","https://openalex.org/W4386541146","https://openalex.org/W2917042095","https://openalex.org/W2915199477","https://openalex.org/W2619503073","https://openalex.org/W2987491222","https://openalex.org/W7160520121","https://openalex.org/W4213010443"],"abstract_inverted_index":{"It":[0],"was":[1,52,128,184],"recently":[2],"found":[3,60],"that":[4,85,98,115,164,239],"patients":[5],"with":[6,94,135],"relapsing":[7],"remitting":[8],"multiple":[9,56],"sclerosis":[10],"exhibit":[11],"widespread":[12],"loss":[13],"of":[14,24,38,75,88,101,143,149,177,182,211,229,235,281],"adenosine-to-inosine":[15],"(A-to-I)":[16],"RNA":[17,28,48,77,90,105,118,127,145,207,218,255],"editing,":[18],"which":[19],"contributes":[20],"to":[21,61,108,139,159,233,264],"the":[22,144,174,180,194],"accumulation":[23,100,234],"immunostimulatory":[25,116,166,258],"double-stranded":[26,103],"Alu":[27,47,104,117,206,237,275],"in":[29,36,54,79,129,168,171,193,268],"circulating":[30],"leukocytes":[31],"and":[32,59,83,132,146,170,190,215,259],"an":[33,99],"attendant":[34],"increase":[35],"levels":[37,87],"proinflammatory":[39],"cytokines":[40],"(e.g.,":[41],"type":[42],"I":[43],"IFNs).":[44],"A":[45],"specific":[46],"(i.e.,":[49,155],"AluJb":[50,126,152,217],"RNA)":[51],"implicated":[53],"activating":[55],"RNA-sensing":[57,150,244],"pathways":[58],"be":[62,120,261],"a":[63,72,209,220,278],"potent":[64],"innate":[65,213,241,284],"immune":[66,285],"agonist.":[67],"Here,":[68],"we":[69,113],"have":[70],"performed":[71],"bioinformatic":[73],"analysis":[74],"A-to-I":[76,89,230],"editing":[78,91,231],"human":[80],"melanoma":[81,197,270],"samples":[82],"determined":[84],"pre-therapy":[86],"negatively":[92],"correlate":[93],"survival":[95,192],"times,":[96],"suggesting":[97],"endogenous":[102],"might":[106],"contribute":[107],"cancer":[109,124,183,288],"patient":[110],"survival.":[111],"Furthermore,":[112],"demonstrated":[114,185],"can":[119,260],"leveraged":[121],"pharmacologically":[122,263],"for":[123,179,225,287],"immunotherapy.":[125,289],"vitro":[130,169],"transcribed":[131],"then":[133],"formulated":[134],"endosome-destabilizing":[136],"polymer":[137,252],"nanoparticles":[138,163],"improve":[140],"intracellular":[141],"delivery":[142],"enable":[147],"activation":[148],"pathways.":[151],"RNA/polymer":[153],"complexes":[154],"Alu-NPs)":[156],"were":[157],"engineered":[158],"form":[160],"colloidally":[161],"stable":[162],"exhibited":[165],"activity":[167],"vivo.":[172],"Finally,":[173],"therapeutic":[175],"potential":[176],"Alu-NPs":[178],"treatment":[181],"by":[186],"attenuated":[187],"tumor":[188,198,266],"growth":[189,267],"prolonged":[191],"B16.F10":[195],"murine":[196],"model.":[199],"Thus,":[200],"these":[201],"data":[202],"collectively":[203],"implicate":[204],"intratumoral":[205],"as":[208,219,277],"potentiator":[210],"antitumor":[212],"immunity":[214,242],"identify":[216,274],"novel":[221],"nucleic":[222,282],"acid":[223,283],"immunotherapeutic":[224],"cancer.":[226],"Significance:":[227],"Loss":[228],"leads":[232],"unedited":[236],"RNAs":[238,276],"activate":[240],"via":[243],"pattern":[245],"recognition":[246],"receptors.":[247],"When":[248],"packaged":[249],"into":[250],"endosome-releasing":[251],"nanoparticles,":[253],"AluJB":[254],"becomes":[256],"highly":[257],"used":[262],"inhibit":[265],"mouse":[269],"models.":[271],"These":[272],"findings":[273],"new":[279],"class":[280],"agonists":[286]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2023-09-10T00:00:00"}